BeeWell

Trials & centers

Ask your doctor

Pick a condition

Recruiting trials

Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer

Phase 1 Recruiting

  • Mayo Clinic, Jacksonville, Florida, United States
  • Moffit Cancer Center, Tampa, Florida, United States
  • UZ Antwerpen, Edegem, Belgium
  • More sites
Official record

INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases

Early phase 1 Recruiting

  • RJ Zuckerberg, Lake Success, New York, United States
Official record

Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors

Phase 1 Recruiting

  • Moffitt Cancer Center, Tampa, Florida, United States
Official record

Improving Care for Rural Patients With Solid Tumors

Phase not listed Recruiting

  • University of Colorado Hospital, Aurora, Colorado, United States
  • Memorial Hospital Central, Colorado Springs, Colorado, United States
  • Memorial Hospital North, Colorado Springs, Colorado, United States
  • More sites
Official record

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Phase 1 Recruiting

  • Exelixis Clinical Site #67, Phoenix, Arizona, United States
  • Exelixis Clinical Site #1, Tucson, Arizona, United States
  • Exelixis Clinical Site #123, Palo Alto, California, United States
  • More sites
Official record

Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors

Phase 1 & 2 Recruiting

  • NEXT Oncology, San Antonio, Texas, United States
  • Hope Cancer Center, Tyler, Texas, United States
  • Medical Oncology, Spokane, Washington, United States
  • More sites
Official record

Malignant Polyp Registry

Observational Recruiting

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
  • More sites
Official record

AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

Phase 1 Recruiting

  • Honor Health Research Institute, Scottsdale, Arizona, United States
  • Florida Cancer Specialists and Research Institute, Sarasota, Florida, United States
  • The University of Chicago, Chicago, Illinois, United States
  • More sites
Official record
ClinicalTrials.gov

NCI-designated centers

Comprehensive & clinical

Alabama

Arizona

California

Colorado

Connecticut

District of Columbia

  • Georgetown Lombardi Comprehensive Cancer Center

    Washington, District of Columbia

Florida

Georgia

Hawai'i

Illinois

Indiana

  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center

    Indianapolis, Indiana

Iowa

Kansas

Kentucky

Maryland

  • Sidney Kimmel Comprehensive Cancer Center

    Baltimore, Maryland

  • University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

    Baltimore, Maryland

Massachusetts

Michigan

Minnesota

Missouri

Nebraska

New Hampshire

New Jersey

New Mexico

  • University of New Mexico Cancer Research and Treatment Center

    Albuquerque, New Mexico

New York

North Carolina

Ohio

Oklahoma

Oregon

Pennsylvania

South Carolina

Tennessee

Texas

Utah

Virginia

Washington

  • Fred Hutchinson/University of Washington/Seattle Children's Cancer Consortium

    Seattle, Washington

Wisconsin

NCI-Designated Cancer Centers, June 10, 2026